Sam Chun Dang Pharm Temporary Shareholders Meeting Result Outside Director Cho Cheol-rae Appointed Voter Turnout 47.6%


  • Sam Chun Dang Pharm held a temporary shareholders meeting on June 30, 2026, and approved the appointment of outside director Cho Cheol-rae as originally proposed.
  • The attendance rate based on total outstanding voting shares was 47.6%, with 100% approval among shares voted and no opposition or abstentions.
  • New outside director Cho Cheol-rae born in 1962 previously served as team leader deputy director and director at the Financial Supervisory Service and currently serves as advisor to Samsung Global Research.
  • The meeting result involves a board change with no capital adjustments or dividend policy modifications.
  • [AI Summary]Sam Chun Dang Pharm strengthened its governance by appointing a former Financial Supervisory Service official as outside director through a temporary shareholders meeting. The attendance rate was 47.6% slightly below half but the agenda passed without shareholder opposition indicating management stability. As a board appointment with no capital change short-term stock price impact is limited.

KOSDAQ Filing Information


  • Result of Extraordinary General Meeting of Shareholders
  • Company: Sam Chun Dang Pharm (000250)
  • Submission: Sam Chun Dang Pharm Co. Ltd
  • Under KRX KOSDAQ Market Division

  • Shares: 23,457,472
  • Price: 238,500 KRW
  • Market Cap: 5,594.6 B KRW